BeOne Medicines (NasdaqGS:BGNE) FY Earnings Call Presentation

T H E F U T U R E I S N O W BeOne Medicines 44th Annual J.P. Morgan Healthcare Conference 2026 JANUARY 13, 2026 Over 25 years, cancer outcomes have dramatically improved, but there is still work to be done 5-year survival rate in U.S. (%)1 Leukemia Myeloma Ovarian Stomach Lung Liver Pancreatic 0% 50% 100% 51 68 15 28 35 62 24 36 44 52 11 22 5 13 1999 - 2001 2015 - 2021 Patients diagnosed: 1 SEER data published April 2025 Leukemia includes ALL, AML, CLL, CML 2 Gene therapy Immuno-oncology Degraders Bispecifi ...